GNU social JP
  • FAQ
  • Login
GNU social JPは日本のGNU socialサーバーです。
Usage/ToS/admin/test/Pleroma FE
  • Public

    • Public
    • Network
    • Groups
    • Featured
    • Popular
    • People

Notices by Eric Topol (erictopol@mstdn.social)

  1. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Monday, 07-Apr-2025 03:42:27 JST Eric Topol Eric Topol

    Excited to get a hold of my new book!

    In conversation about 2 months ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/114/292/471/007/731/643/original/efe4afdb2cf1a8f3.png
  2. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Sunday, 05-Jan-2025 06:33:19 JST Eric Topol Eric Topol

    The scientist who is responsible for driving GLP-1 drugs for the treatment of obesity and testing them for prevention of Alzheimer's disease—Lotte Bjerre Knudsen— tells her story in a remarkable conversation. Full transcript, or video, all free, no ads.
    https://erictopol.substack.com/p/lotte-bjerre-knudsen-the-scientist

    In conversation about 5 months ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/113/771/521/053/153/126/original/ce832d7abbc7e194.png
    2. Domain not in remote thumbnail source whitelist: substackcdn.com
      Lotte Bjerre Knudsen: The Scientist Who Drove GLP-1 Drugs For Obesity and Alzheimer's
      from Eric Topol
      Facts, data, and analytics about biomedical matters.
  3. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Thursday, 22-Aug-2024 01:33:17 JST Eric Topol Eric Topol

    My PBS segment on the current Covid wave
    https://www.pbs.org/newshour/show/what-to-know-about-this-summers-major-surge-in-covid-infections

    In conversation about 9 months ago from mstdn.social permalink

    Attachments

    1. Domain not in remote thumbnail source whitelist: d3i6fh83elv35t.cloudfront.net
      What to know about this summer’s major surge in COVID infections
      As summer winds down, much of the U.S. is seeing the biggest COVID wave in at least two years, and hundreds of people are still being killed by the virus every week. According to a CDC analysis of hospitalizations, 25 states have or likely have rising numbers of COVID infections. William Brangham speaks with Dr. Eric Topol about what’s behind the uptick and how people can protect themselves.
  4. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Thursday, 01-Aug-2024 13:31:53 JST Eric Topol Eric Topol
    • Trish Greenhalgh

    This new review on LongCovid is outstanding
    https://thelancet.com/journals/lancet/article/PIIS0140-6736(24)01136-X/fulltext by @trishgreenhalgh and colleagues

    In conversation about 10 months ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/883/854/461/764/208/original/75a5e30db3df86b8.png

    2. https://media.mstdn.social/media_attachments/files/112/883/854/934/986/696/original/3dc34a66a44a02b7.png

  5. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Wednesday, 31-Jul-2024 05:57:43 JST Eric Topol Eric Topol

    We knew about loss of smell and taste with Covid infections. A nationwide report from S Korea found a 3.5-fold increase in hearing loss among young adults
    https://thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00338-9/fulltext

    In conversation about 10 months ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/876/211/203/697/357/original/5f6cf83f70f8777c.jpeg

  6. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Friday, 26-Jul-2024 04:35:07 JST Eric Topol Eric Topol

    Bad air quality and poor ventilation greatly contributed to the spread of Covid. Lessons learned
    https://www.science.org/doi/10.1126/science.adp2241

    In conversation about 10 months ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/848/662/974/517/013/original/62ff7a675b2c00ca.png

  7. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Wednesday, 10-Jul-2024 02:05:00 JST Eric Topol Eric Topol

    Be careful out there. The KP.x variants summer wave
    https://latimes.com/california/story/2024-07-08/playing-covid-roulette-some-infected-by-flirt-variants-report-their-most-unpleasant-symptoms-yet

    In conversation about 11 months ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/757/484/839/969/458/original/01bdfb2e48c392c5.png

    2. https://media.mstdn.social/media_attachments/files/112/757/485/545/220/467/original/43404c281f00ca9c.png
    3. Domain not in remote thumbnail source whitelist: ca-times.brightspotcdn.com
      'Playing COVID roulette': Some infected by FLiRT variants report their most unpleasant symptoms yet
      from https://www.latimes.com/people/rong-gong-lin-ii
      COVID cases and hospitalizations rise in L.A. County — and some of those recently reinfected with the FLiRT variants are finding the latest bout the worst yet.
  8. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Wednesday, 26-Jun-2024 03:04:21 JST Eric Topol Eric Topol

    A huge study of #LongCovid in South Korea and Japan
    shows a pronounced increase of Guillain-Barré syndrome, cognitive deficit, insomnia, anxiety disorder, encephalitis, ischemic stroke and mood disorder. Reduced by vaccination
    https://nature.com/articles/s41562-024-01895-8

    In conversation about a year ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/678/212/176/103/181/original/5c691d33086830a2.jpeg
    2. Domain not in remote thumbnail source whitelist: media.springernature.com
      Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan - Nature Human Behaviour
      from Fusar-Poli, Paolo
      Using propensity score matching, Kim et al. find evidence of higher short- and long-term risk of adverse neuropsychiatric outcomes in Korean and Japanese cohorts of individuals infected with SARS-CoV-2 than in the general population.
  9. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Saturday, 15-Jun-2024 08:44:01 JST Eric Topol Eric Topol

    Very good news on the fall booster. The FDA changed course from JN.1 to select KP.2, which in the animal model has a >3-fold induction of neutralizing antibodies vs KP.3, the SARS-CoV2 variant that is on its way to dominance in the US (and causing trouble in multiple countries)
    https://www.nbcnews.com/health/health-news/fda-recommends-covid-vaccine-update-target-kp2-strain-rcna157089

    In conversation about a year ago from mstdn.social permalink

    Attachments

    1. Domain not in remote thumbnail source whitelist: media-cldnry.s-nbcnews.com
      FDA advises Covid vaccine makers to target KP.2 for fall shots
      from NBCNews
      The selection comes as Covid cases are rising in some parts of the country.
  10. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Saturday, 08-Jun-2024 00:34:01 JST Eric Topol Eric Topol

    The KP.3 variant is taking over in the US, with 2 key mutations beyond JN.1 (F456L and Q493E) at the same time FDA has planned for JN.1 to be the target of the new Covid booster in September. Big mismatch and bad call.

    In conversation about a year ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/575/885/893/846/297/original/8bd206fd5c1aa22c.png
  11. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Thursday, 30-May-2024 16:56:49 JST Eric Topol Eric Topol

    What if there was an antibiotic that doesn't disrupt the gut microbiome?
    There is now.
    A discovery published at Nature today
    https://nature.com/articles/s41586-024-07502-0

    In conversation about a year ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/527/526/144/210/103/original/57b3ab38d5b63402.jpeg
    2. Domain not in remote thumbnail source whitelist: media.springernature.com
      A Gram-negative-selective antibiotic that spares the gut microbiome - Nature
      from Hergenrother, Paul J.
      Lolamicin, a novel antibiotic developed from a pyridinepyrazole precursor, exhibits potent activity against a broad range of Gram-negative multidrug-resistant clinical isolates, and good efficacy in mouse models of infection without inducing gut dysbiosis.
  12. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Sunday, 26-May-2024 09:39:31 JST Eric Topol Eric Topol

    The process leading to Alzheimer's disease takes about 20 years to develop, giving more than ample opportunity to identify high-risk individuals and change the natural history.
    Discussed in the new Ground Truths
    https://erictopol.substack.com/p/medical-forecasting
    and in this week's Science Magazine
    https://www.science.org/doi/10.1126/science.adp7977

    In conversation about a year ago from mstdn.social permalink

    Attachments



    1. https://media.mstdn.social/media_attachments/files/112/504/033/917/116/718/original/3603e0adaa63dc8b.png
    2. Domain not in remote thumbnail source whitelist: substackcdn.com
      Medical Forecasting
      from Eric Topol
      The exciting opportunity to provide highly accurate risk and timing assessment at the individual level for actionable conditions to potentiate prevention
  13. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Tuesday, 21-May-2024 04:43:49 JST Eric Topol Eric Topol

    The highly pro-inflammatory and pervasive microplastics and nanoplastics: previously found in arteries and associated with increased in heart attacks and strokes, now in all human testes that were assessed.

    https://erictopol.substack.com/p/theres-plastic-in-my-plaque

    https://academic.oup.com/toxsci/advance-article-abstract/doi/10.1093/toxsci/kfae060/7673133?redirectedFrom=fulltext&login=false#no-access-

    In conversation about a year ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/475/081/170/880/045/original/3781dcf82a1c4abb.png
  14. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Thursday, 16-May-2024 08:32:35 JST Eric Topol Eric Topol

    https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00410-X/fulltext

    First clinical trial of a pan-coronavirus vaccine , Phase 1 results, looks encouraging

    In conversation about a year ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/447/637/782/862/721/original/d8f415307745cf00.jpeg

  15. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Thursday, 25-Apr-2024 05:39:12 JST Eric Topol Eric Topol

    An update on H5N1 bird flu from the USDA, CDC, FDA joint briefing session today
    https://erictopol.substack.com/p/a-bird-flu-h5n1-status-report

    In conversation about a year ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/328/104/591/114/457/original/17b989d1a531d81a.png
    2. Domain not in remote thumbnail source whitelist: substackcdn.com
      A Bird Flu H5N1 Status Report
      from Eric Topol
      Updates from a joint USDA, CDC, FDA Joint Briefing Session Today
  16. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Wednesday, 24-Apr-2024 08:56:04 JST Eric Topol Eric Topol

    This isn't good, folks.
    I'm not worried about H5N1 transmission to humans (yet) but the USDA pathetic lack of transparency, how long it took for the genomes to be released, lack of testing asymptomatic cattle......
    All detracts from "confidence"

    In conversation about a year ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/322/975/085/476/046/original/a1f43e4175891d86.png
  17. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Friday, 19-Apr-2024 12:12:35 JST Eric Topol Eric Topol

    A Covid update

    https://erictopol.substack.com/p/are-we-flirting-with-a-new-covid

    In conversation about a year ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/295/648/811/385/489/original/cc3679d5317286eb.png
    2. Domain not in remote thumbnail source whitelist: substackcdn.com
      Are We FLiRTing With A New Covid Wave?
      from Eric Topol
      A Covid Update
  18. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Thursday, 04-Apr-2024 07:54:54 JST Eric Topol Eric Topol

    Paxlovid didn’t provide any benefit in a placebo-controlled randomized trial in lower risk (mean age 42 years) outpatients with mild-to-moderate Covid

    https://www.nejm.org/doi/full/10.1056/NEJMoa2309003

    In conversation about a year ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/209/463/975/745/403/original/331df327e5d9cddd.png

  19. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Wednesday, 13-Mar-2024 08:36:38 JST Eric Topol Eric Topol

    Covid vaccination markedly reduced blood clots, heart attacks, heart failure, stroke and other adverse cardiovascular outcomes, as seen from over 20 million people, about half of whom were vaccinated https://heart.bmj.com/content/early/2024/01/24/heartjnl-2023-323483

    In conversation about a year ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/085/299/234/395/991/original/ec970dc947de7a6a.png
    2. Domain not in remote thumbnail source whitelist: heart.bmj.com
      The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications
      Objective To study the association between COVID-19 vaccination and the risk of post-COVID-19 cardiac and thromboembolic complications. Methods We conducted a staggered cohort study based on national vaccination campaigns using electronic health records from the UK, Spain and Estonia. Vaccine rollout was grouped into four stages with predefined enrolment periods. Each stage included all individuals eligible for vaccination, with no previous SARS-CoV-2 infection or COVID-19 vaccine at the start date. Vaccination status was used as a time-varying exposure. Outcomes included heart failure (HF), venous thromboembolism (VTE) and arterial thrombosis/thromboembolism (ATE) recorded in four time windows after SARS-CoV-2 infection: 0–30, 31–90, 91–180 and 181–365 days. Propensity score overlap weighting and empirical calibration were used to minimise observed and unobserved confounding, respectively. Fine-Gray models estimated subdistribution hazard ratios (sHR). Random effect meta-analyses were conducted across staggered cohorts and databases. Results The study included 10.17 million vaccinated and 10.39 million unvaccinated people. Vaccination was associated with reduced risks of acute (30-day) and post-acute COVID-19 VTE, ATE and HF: for example, meta-analytic sHR of 0.22 (95% CI 0.17 to 0.29), 0.53 (0.44 to 0.63) and 0.45 (0.38 to 0.53), respectively, for 0–30 days after SARS-CoV-2 infection, while in the 91–180 days sHR were 0.53 (0.40 to 0.70), 0.72 (0.58 to 0.88) and 0.61 (0.51 to 0.73), respectively. Conclusions COVID-19 vaccination reduced the risk of post-COVID-19 cardiac and thromboembolic outcomes. These effects were more pronounced for acute COVID-19 outcomes, consistent with known reductions in disease severity following breakthrough versus unvaccinated SARS-CoV-2 infection. Data may be obtained from a third party and are not publicly available. CPRD: CPRD data were obtained under the CPRD multi-study license held by the University of Oxford after Research Data Governance (RDG) approval. Direct data sharing is not allowed. SIDIAP: In accordance with current European and national law, the data used in this study is only available for the researchers participating in this study. Thus, we are not allowed to distribute or make publicly available the data to other parties. However, researchers from public institutions can request data from SIDIAP if they comply with certain requirements. Further information is available online () or by contacting SIDIAP (sidiap@idiapjgol.org). CORIVA: CORIVA data were obtained under the approval of Research Ethics Committee of the University of Tartu and the patient level data sharing is not allowed. All analyses in this study were conducted in a federated manner, where analytical code and aggregated (anonymised) results were shared, but no patient-level data was transferred across the collaborating institutions.
  20. Embed this notice
    Eric Topol (erictopol@mstdn.social)'s status on Wednesday, 13-Mar-2024 06:45:00 JST Eric Topol Eric Topol

    Beyond ~30 million excess deaths, "The COVID-19 pandemic caused the most severe drops in life expectancy seen in 50+ years."
    https://healthdata.org/research-analysis/library/mortality-life-expectancy-and-population

    https://thelancet.com/journals/lancet/article/PIIS0140-6736(24)00476-8/fulltext

    In conversation about a year ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/112/084/678/912/017/275/original/1c207779300f5951.jpeg
    2. Domain not in remote thumbnail source whitelist: www.healthdata.org
      Mortality, life expectancy, and population
      The COVID-19 pandemic caused the most severe drops in life expectancy seen in 50+ years.

  • Before

User actions

    Eric Topol

    Eric Topol

    physician-scientist, author, editor

    Tags
    • (None)

    Following 0

      Followers 0

        Groups 0

          Statistics

          User ID
          28946
          Member since
          17 Nov 2022
          Notices
          107
          Daily average
          0

          Feeds

          • Atom
          • Help
          • About
          • FAQ
          • TOS
          • Privacy
          • Source
          • Version
          • Contact

          GNU social JP is a social network, courtesy of GNU social JP管理人. It runs on GNU social, version 2.0.2-dev, available under the GNU Affero General Public License.

          Creative Commons Attribution 3.0 All GNU social JP content and data are available under the Creative Commons Attribution 3.0 license.